Join forces with a leader in exosome regenerative medicine. We offer flexible partnership models from licensing to co-development, tailored to your strategic objectives.
Whether you are a pharma company, academic institution, healthcare provider, or investor, we have a partnership model designed for your needs.
License our exosome platforms or specific product candidates for development and commercialization in your territory. Exclusive and non-exclusive options available.
Joint research programs to advance pipeline candidates through clinical development. Shared IP, shared risk, shared reward with clear milestone-based governance.
Leverage our GMP-capable 3D bioreactor platform for custom exosome manufacturing. From research-grade to clinical-grade, with full analytical support.
Investigator-initiated study support, clinical site access through our hospital network, and regulatory consulting for exosome-based clinical trials.
Access our disease model library, targeting platform, and analytical tools for your research programs. Material transfer agreements with rapid turnaround.
Equity and project-level investment opportunities for investors seeking exposure to the rapidly growing exosome therapeutics market.
Confidential exploration of mutual interests and strategic alignment
Mutual technical and commercial assessment with NDA in place
Negotiation of commercial terms, milestones, and governance structure
Formal agreement signing and kickoff of joint project activities
Start a confidential conversation about partnership opportunities.
Contact Our BD Team